Pandemic Expected To Drive Rolling Review Upsurge At EMA
Agency Will Demand 50% of Full MAA Fee Upfront
The European Medicines Agency is anticipating greater use of its rolling review process during the coronavirus pandemic. Companies who use it will be asked to pay upfront half of what they would pay for a full marketing application.
